Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Revenues	$ 20,656	$ 20,009	$ 71,569	$ 81,298
Operating costs and expenses
Medical professional and license fees	4,554	4,648	15,518	19,139
Direct costs of services	9,886	10,068	29,376	33,477
General and administrative expenses	2,791	3,037	8,847	10,151
Marketing and advertising	4,981	4,803	16,918	18,283
Depreciation	516	1,223	1,555	3,743
Restructuring and impairment	(5)	10	214	47
	22,723	23,789	72,428	84,840
Gain on sale of assets	65	33	180	221
Operating loss	(2,002)	(3,747)	(679)	(3,321)
Net investment income and other	225	220	676	498
Loss before taxes on income	(1,777)	(3,527)	(3)	(2,823)
Income tax (benefit) expense	(217)	22	(111)	70
Net (loss) income	(1,560)	(3,549)	108	(2,893)
(Loss) earnings per common share
Basic (in Dollars per share)	$ (0.08)	$ (0.19)	$ 0.01	$ (0.15)
Diluted (in Dollars per share)	$ (0.08)	$ (0.19)	$ 0.01	$ (0.15)
Weighted average shares outstanding
Basic (in Shares)	19,241	19,017	19,182	18,968
Diluted (in Shares)	19,241	19,017	19,332	18,968
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment	92	189	(150)	167
Unrealized investment gain	0	0	0	30
Total other comprehensive income (loss), net of tax	92	189	(150)	197
Comprehensive loss	$ (1,468)	$ (3,360)	$ (42)	$ (2,696)